Modification of preoperative radiochemotherapy for esophageal cancer (CROSS protocol) is safe and efficient with no impact on surgical morbidity | Strahlentherapie und Onkologie
Schedule of enrolment, interventions, and assessments | Download Scientific Diagram
ASCO 2021–Gastroesophageal tumor highlights | memo - Magazine of European Medical Oncology
Evolving treatment paradigms in esophageal cancer. - Abstract - Europe PMC
Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma | British Journal of Cancer
CROSS Trial - Neoadjuvant ChemoRT for Esophageal Cancer
Esophageal Cancer Updates. - ppt download
Preoperative pembrolizumab combined with chemoradiotherapy for esophageal squamous cell carcinoma: Trial design - ScienceDirect
Cross trial esophagus updated result | PPT
CROSS Trial: Esophageal Cancer, Surgery, and Neoadjuvant Therapy | BTK/RAS-ACS Journal Club #9
Current Oncology | Free Full-Text | Immunotherapy in Squamous Cell Cancer of the Esophagus
Summary of the CROSS phase III randomized trial that assessed the role... | Download Table
Can the CROSS protocol be safely implemented in real world scenario with broader eligibility criteria? Experience from a tertiary care centre in India - ecancer
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS) | BMC Cancer | Full Text
ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286) | BMC Cancer | Full ...
Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma | Journal of Gastrointestinal Surgery
Cross trial esophagus updated result | PPT
PDF) ESOPEC: Prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
Neoadjuvant treatment strategy for locally advanced thoracic esophageal cancer. - Abstract - Europe PMC
Cross trial esophagus updated result | PPT
Cross trial esophagus updated result | PPT
Cross trial esophagus updated result | PPT
View All Pages | Cancer.Net
![PDF] Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/630bc6b873bf8304e24a6ac1260e289c3deac5d2/5-Figure1-1.png "PDF] Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol | Semantic Scholar")
PDF] Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol | Semantic Scholar
Neo-AEGIS Trial Finds Two Approaches Comparable in Treating Advanced Esophageal Cancer - The ASCO Post
Cross trial esophagus updated result | PPT
Cross trial esophagus updated result | PPT
Cancers | Free Full-Text | Advancing Esophageal Cancer Treatment: Immunotherapy in Neoadjuvant and Adjuvant Settings
